Moderna Inc (MRNA)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 3,236,000 | 6,848,000 | 19,263,000 | 17,736,000 | 274,490 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $3,236,000K ÷ $—K
= —
The data provided shows that Moderna Inc's receivables turnover ratio is not available for the years 2020, 2021, 2022, 2023, and 2024. The lack of information regarding the receivables turnover ratio could potentially indicate that the company does not disclose this particular financial metric or that there may be specific circumstances surrounding the collection of receivables that are not reflected in the available data.
Analyzing the receivables turnover ratio can provide insights into how efficiently the company is collecting outstanding payments from its customers. A higher turnover ratio typically indicates that the company is collecting receivables more quickly, which is generally preferable as it signifies better liquidity and lower credit risk. Conversely, a lower turnover ratio may suggest potential issues with collection practices or an increase in outstanding receivables.
Due to the absence of data for Moderna Inc's receivables turnover ratio, further examination and comparison with industry benchmarks or historical trends would be necessary to assess the company's performance in managing its receivables effectively.
Peer comparison
Dec 31, 2024